Delivery Order SPE2DB22D3016-SPE2DB25FAKZ8

Award Date 1/22/25
Potential Completion Date 1/23/25
Potential Value $5.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,301.06, is a delivery order for 4,567,903,372 units of the drug Phenazopyridine 200 mg tablets. The contract has an ultimate completion date of April 15, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,419.18 firm fixed-price delivery order is for the supply of PHENAZOPYRD 100MG 100S, a pharmaceutical product. The contract has an ultimate completion date of November 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,682.58 firm-fixed-price delivery order is for the supply of Phenazopyridine 200 mg tablets in 100-count bottles. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,984.80, is for the provision of 4562774485 - PHENAZOPYRIDINE 100 MG TAB 100S, a medication used to treat urinary tract infections. The contract has an ultimate completion date of November 13, 2023 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,473.34, is a delivery order with a firm fixed price for the supply of "PHENOHYTRO ELIXIR 120ML" medical products. The ultimate completion date for this order is February 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,492.88 firm-fixed-price delivery order is for PYLERA CAPSULE UU 120S, a pharmaceutical product. The contract has an ultimate completion date of November 6, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,709.07 delivery order is for PYLERA CAPSULE UU 120S, a pharmaceutical product. The contract has an ultimate completion date of April 17, 2023 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,989.68 firm fixed-price delivery order, awarded on February 15, 2024, supports the supply of a wide range of pharmaceutical products and medical supplies to federal healthcare programs. The contract has an ultimate completion date of February 16, 2024 and is not designated with a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $566,799.33 firm-fixed-price delivery order is for general pharmaceutical items required by the agency. The contract has an ultimate completion date of September 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $151,889.28 firm-fixed-price delivery order contract, awarded on January 29, 2025, is for the supply of various pharmaceutical products and medical supplies to support military healthcare programs. The contract has an ultimate completion date of January 30, 2025 and is not designated as a set-aside....
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAKZ8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,572.37 firm-fixed-price delivery order is for the supply of 4,567,013,416 units of the drug PHENAZOPYRIDINE 200 MG TAB 100S. The contract has an ultimate completion date of January 23, 2025.

Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 4/23/25, 10:44 AM